{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:20:06Z","timestamp":1793658006675,"version":"4.5.1"},"reference-count":52,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["TA\/F\/21\/210034"],"award-info":[{"award-number":["TA\/F\/21\/210034"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GOSH Charity Love Hearts Appeal","award":["W1178"],"award-info":[{"award-number":["W1178"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,27]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cardiac allograft vasculopathy (CAV) is a critical predictor of the long-term success of heart transplantation and once it is established, progression to graft dysfunction and loss is inevitable, despite adherence to immunosuppression and medications that ameliorate cardiac risk factors. Regulatory T cells (Tregs) are key for maintaining immune balance in the periphery. Studies investigating adoptive transfer of ex vivo expanded Tregs isolated from blood have been shown to be feasible and safe with good evidence for Tregs reducing CAV lesions in animal models of transplantation. Here, we describe the protocol for the ATT-Heart Study which is a phase I clinical trial investigating autologous thymus-derived Treg cell therapy in nine paediatric heart transplant recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Patients will be recruited from the heart transplant waiting list at Great Ormond Street Hospital. Individualised autologous thymus-derived and expanded Tregs (TR006) will be injected into patients 3\u20136 months after transplant and follow-up will be conducted as per the post-transplant standard of care protocol with no wean of standard of care immunosuppression. Primary endpoint includes occurrence of Dose-limiting Toxicities in patients receiving TR006. Further data from blood tests, endomyocardial biopsy tissue, coronary imaging and clinical follow-up will be collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This article is based on the ATT-Heart study Protocol (V.1.1; dated 19 December 2024). The ATT-Heart trial has received a favourable ethical opinion from the Health Research Authority and South-Central Oxford A Research Ethics Committee (IRAS Number: 1008875\/REC reference: 24\/SC\/0333). Clinical trials authorisation approval from UK Medicines and Healthcare products Regulatory Agency has also been received. The clinical trial will be conducted in accordance with the principles of Good Clinical Practice and following the guidelines set as part of the Research Governance Framework for Health and Social Care and all applicable necessary local policies. It is intended that the findings of the clinical trial will be presented at national\/international conferences and using social media and through patient groups for dissemination among their members. The results will also be published in international peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN15374803\">ISRCTN15374803<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108683","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:35:23Z","timestamp":1779388523000},"page":"e108683","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Protocol for a phase I single-centre dose escalation trial of autologous thymus derived regulatory T cells in paediatric heart transplant recipients to prevent cardiac allograft vasculopathy (ATT-Heart)"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn15374803","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct04924491","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04924491","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Apoorva","family":"Aiyengar","sequence":"first","affiliation":[{"name":"Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Fanelli","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Romano","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-0130","authenticated-orcid":false,"given":"Prakash","family":"Patel","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Issa","sequence":"additional","affiliation":[{"name":"University of Oxford Nuffield Department of Surgical Sciences, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilveer","family":"Panesar","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarajan","family":"Muthialu","sequence":"additional","affiliation":[{"name":"Paediatric Cardiothoracic Surgery, Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Douiri","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Burch","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, London, UK"},{"name":"Institute of Cardiovascular Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026052111351237000_16.5.e108683.1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2017.07.018","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time","volume":"36","author":"Rossano","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026052111351237000_16.5.e108683.2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12055-019-00820-3","article-title":"Pediatric heart transplantation: long-term outcomes","volume":"36","author":"Dipchand","year":"2020","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"2026052111351237000_16.5.e108683.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2022.01.406","article-title":"Long-Term Survivors Following Pediatric Heart Transplantation: A PHTS Database Analysis","volume":"41","author":"Hayes","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2026052111351237000_16.5.e108683.4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5500\/wjt.v4.i4.276","article-title":"Diagnosis and management of coronary allograft vasculopathy in children and adolescents","volume":"4","author":"Dedieu","year":"2014","journal-title":"World J Transplant"},{"key":"2026052111351237000_16.5.e108683.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2012.00666.x"},{"key":"2026052111351237000_16.5.e108683.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.045"},{"key":"2026052111351237000_16.5.e108683.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.09.016"},{"key":"2026052111351237000_16.5.e108683.8","first-page":"303","article-title":"Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies","volume":"23","author":"Spartalis","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026052111351237000_16.5.e108683.9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.4.1783"},{"key":"2026052111351237000_16.5.e108683.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.029"},{"key":"2026052111351237000_16.5.e108683.11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"2026052111351237000_16.5.e108683.12","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh207"},{"key":"2026052111351237000_16.5.e108683.13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00232","article-title":"Peripherally induced tregs - role in immune homeostasis and autoimmunity","volume":"4","author":"Yadav","year":"2013","journal-title":"Front Immunol"},{"key":"2026052111351237000_16.5.e108683.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0038"},{"key":"2026052111351237000_16.5.e108683.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.03.016"},{"key":"2026052111351237000_16.5.e108683.16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2404","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026052111351237000_16.5.e108683.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30167-7"},{"key":"2026052111351237000_16.5.e108683.18","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14415"},{"key":"2026052111351237000_16.5.e108683.19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"2026052111351237000_16.5.e108683.20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"S\u00e1nchez-Fueyo","year":"2020","journal-title":"Am J Transplant"},{"key":"2026052111351237000_16.5.e108683.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230183"},{"key":"2026052111351237000_16.5.e108683.22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.it.2021.11.001","article-title":"Towards regulatory cellular therapies in solid organ transplantation","volume":"43","author":"Bottomley","year":"2022","journal-title":"Trends Immunol"},{"key":"2026052111351237000_16.5.e108683.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-293795"},{"key":"2026052111351237000_16.5.e108683.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564401"},{"key":"2026052111351237000_16.5.e108683.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.06.001"},{"key":"2026052111351237000_16.5.e108683.26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697854","article-title":"Regulatory T Cells in GVHD Therapy","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"2026052111351237000_16.5.e108683.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2009.05.003"},{"key":"2026052111351237000_16.5.e108683.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2008.11.036","article-title":"30: CD4+CD25+ Regulatory T-Cells and Cardiac Allograft Vasculopathy","volume":"28","author":"Sherman","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2026052111351237000_16.5.e108683.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000265446.61754.d2"},{"key":"2026052111351237000_16.5.e108683.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04065.x"},{"key":"2026052111351237000_16.5.e108683.31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/sji.12064","article-title":"\u03b3\u03b4 T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion","volume":"78","author":"Zhu","year":"2013","journal-title":"Scand J Immunol"},{"key":"2026052111351237000_16.5.e108683.32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/TP.0000000000000329","article-title":"Depletion of T regulatory cells promotes natural killer cell-mediated cardiac allograft vasculopathy","volume":"98","author":"Hirohashi","year":"2014","journal-title":"Transplantation"},{"key":"2026052111351237000_16.5.e108683.33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15212"},{"key":"2026052111351237000_16.5.e108683.34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444924","article-title":"The potential of autologous regulatory T cell (Treg) therapy to prevent Cardiac Allograft Vasculopathy (CAV) in paediatric heart transplant recipients","volume":"15","author":"Aiyengar","year":"2024","journal-title":"Front Immunol"},{"key":"2026052111351237000_16.5.e108683.35","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ff8772"},{"key":"2026052111351237000_16.5.e108683.36","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2154"},{"key":"2026052111351237000_16.5.e108683.37","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30167-7"},{"key":"2026052111351237000_16.5.e108683.38","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/TP.0000000000005065","article-title":"Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation","volume":"108","author":"Brook","year":"2024","journal-title":"Transplantation"},{"key":"2026052111351237000_16.5.e108683.39","doi-asserted-by":"crossref","first-page":"100561","DOI":"10.1016\/j.medj.2024.11.014","article-title":"Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants","volume":"6","author":"McCallion","year":"2025","journal-title":"Med"},{"key":"2026052111351237000_16.5.e108683.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061864","article-title":"Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients","volume":"12","author":"Brook","year":"2022","journal-title":"BMJ Open"},{"key":"2026052111351237000_16.5.e108683.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-023-03157-7","article-title":"Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial","volume":"24","author":"Dudreuilh","year":"2023","journal-title":"BMC Nephrol"},{"key":"2026052111351237000_16.5.e108683.42","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjad212.1129","article-title":"P999 First in human treatment of Crohn\u2019s disease with autologous ex-vivo expanded polyclonal, gut-targeted regulatory T cells: Initial results of the TRIBUTE feasibility study","volume":"18","author":"Irving","year":"2024","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"2026052111351237000_16.5.e108683.43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transplant"},{"key":"2026052111351237000_16.5.e108683.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2019.10.011"},{"key":"2026052111351237000_16.5.e108683.45","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/eji.202048949","article-title":"Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients","volume":"51","author":"Romano","year":"2021","journal-title":"Eur J Immunol"},{"key":"2026052111351237000_16.5.e108683.46","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J Transl Med"},{"key":"2026052111351237000_16.5.e108683.47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893576","article-title":"A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy","volume":"13","author":"Bernaldo-de-Quir\u00f3s","year":"2022","journal-title":"Front Immunol"},{"key":"2026052111351237000_16.5.e108683.48","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001152","article-title":"The Presence of a Marked Imbalance Between Regulatory T Cells and Effector T Cells Reveals That Tolerance Mechanisms Could Be Compromised in Heart Transplant Children","volume":"7","author":"Bernaldo-de-Quir\u00f3s","year":"2021","journal-title":"Transplant Direct"},{"key":"2026052111351237000_16.5.e108683.49","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13930","article-title":"T cell phenotype in paediatric heart transplant recipients","volume":"25","author":"Mengrelis","year":"2021","journal-title":"Pediatr Transplant"},{"key":"2026052111351237000_16.5.e108683.50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5414\/CPP48214","article-title":"Pharmacokinetics and pharmacodynamics of basiliximab in Japanese pediatric renal transplant patients","volume":"48","author":"Nagai","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2026052111351237000_16.5.e108683.51","first-page":"258","article-title":"The significance of neonatal thymectomy for shaping the immune system in children with congenital heart defects","volume":"14","author":"Stosio","year":"2017","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"2026052111351237000_16.5.e108683.52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10875-021-01059-7","article-title":"Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment","volume":"41","author":"Collins","year":"2021","journal-title":"J Clin Immunol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:35:27Z","timestamp":1779388527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,21]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-108683"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108683","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}